Patient characteristics in the two NS grading systems
| Clinical feature . | BNLI grading . | New GHSG grading . | ||
|---|---|---|---|---|
| NS1 (n = 674) . | NS2 (n = 174) . | NS-LR (n = 420) . | NS-HR (n = 423) . | |
| % . | % . | % . | % . | |
| Age, y | ||||
| Younger than 20 | 12 | 9 | 12 | 11 | 
| 20-29 | 40 | 39 | 38 | 43 | 
| 30-39 | 25 | 24 | 28 | 22 | 
| 40-49 | 11 | 17 | 12 | 12 | 
| 50-59 | 8 | 7 | 7 | 8 | 
| 60 and older | 3 | 5 | 3 | 4 | 
| Sex | ||||
| Male | 47 | 49 | 45 | 49 | 
| Female | 53 | 51 | 55 | 51 | 
| Stage | ||||
| I | 8 | 11 | 11 | 7 | 
| II | 49 | 47 | 47 | 50 | 
| III | 28 | 27 | 29 | 28 | 
| IV | 14 | 16 | 13 | 15 | 
| B symptoms | 42 | 49 | 41 | 45 | 
| Mediastinal4-150 | 23 | 30 | 22 | 27 | 
| Extranodal4-151 | 23 | 29 | 23 | 26 | 
| High ESR‡ | 53 | 58 | 51 | 58 | 
| Low hemoglobin value4-153, g/dL | 13 | 27 | 15 | 15 | 
| IPS29 | ||||
| 0 | 23 | 17 | 25 | 19 | 
| 1 | 36 | 32 | 36 | 34 | 
| 2 | 23 | 25 | 22 | 25 | 
| 3 | 12 | 16 | 11 | 14 | 
| 4 | 4 | 9 | 5 | 5 | 
| 5 | 1 | 2 | 1 | 2 | 
| 6 | 0 | 1 | 0 | 0 | 
| CR | 90 | 80 | 92 | 84 | 
| PR | 4 | 2 | 3 | 3 | 
| PRO | 6 | 18 | 4 | 12 | 
| Relapse | 21 | 29 | 17 | 28 | 
| Clinical feature . | BNLI grading . | New GHSG grading . | ||
|---|---|---|---|---|
| NS1 (n = 674) . | NS2 (n = 174) . | NS-LR (n = 420) . | NS-HR (n = 423) . | |
| % . | % . | % . | % . | |
| Age, y | ||||
| Younger than 20 | 12 | 9 | 12 | 11 | 
| 20-29 | 40 | 39 | 38 | 43 | 
| 30-39 | 25 | 24 | 28 | 22 | 
| 40-49 | 11 | 17 | 12 | 12 | 
| 50-59 | 8 | 7 | 7 | 8 | 
| 60 and older | 3 | 5 | 3 | 4 | 
| Sex | ||||
| Male | 47 | 49 | 45 | 49 | 
| Female | 53 | 51 | 55 | 51 | 
| Stage | ||||
| I | 8 | 11 | 11 | 7 | 
| II | 49 | 47 | 47 | 50 | 
| III | 28 | 27 | 29 | 28 | 
| IV | 14 | 16 | 13 | 15 | 
| B symptoms | 42 | 49 | 41 | 45 | 
| Mediastinal4-150 | 23 | 30 | 22 | 27 | 
| Extranodal4-151 | 23 | 29 | 23 | 26 | 
| High ESR‡ | 53 | 58 | 51 | 58 | 
| Low hemoglobin value4-153, g/dL | 13 | 27 | 15 | 15 | 
| IPS29 | ||||
| 0 | 23 | 17 | 25 | 19 | 
| 1 | 36 | 32 | 36 | 34 | 
| 2 | 23 | 25 | 22 | 25 | 
| 3 | 12 | 16 | 11 | 14 | 
| 4 | 4 | 9 | 5 | 5 | 
| 5 | 1 | 2 | 1 | 2 | 
| 6 | 0 | 1 | 0 | 0 | 
| CR | 90 | 80 | 92 | 84 | 
| PR | 4 | 2 | 3 | 3 | 
| PRO | 6 | 18 | 4 | 12 | 
| Relapse | 21 | 29 | 17 | 28 | 
% indicates column percentage; CR, complete remission; PR, partial remission; PRO, progressive disease.
Large mediastinal tumor greater than or equal to one third of maximal transversal thoracic diameter (measured in a sagittal x-ray film).
Extranodal involvement.
Erythrocyte sedimentation rate 50 mm/h or higher without B symptoms or 30 mm/h or higher with B symptoms.
Hemoglobin 12 g/dL or less for men and 10.5 g/dL or less for women.